載入...
Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists
Antagonists of peripheral type 1 cannabinoid receptors (CB1) may have utility in the treatment of obesity, liver disease, metabolic syndrome and dyslipidemias. We have targeted the purine otenabant (1) analogues for this purpose. The non-tissue selective CB1 antagonist rimonabant (2) was approved as...
Na minha lista:
| 發表在: | Bioorg Med Chem |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6129194/ https://ncbi.nlm.nih.gov/pubmed/30077609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2018.07.043 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|